<DOC>
	<DOCNO>NCT02905942</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety PEG-rhG-CSF recovery hematopoietic function autologous stem cell transplantation patient lymphoma .</brief_summary>
	<brief_title>PEG-rhG-CSF Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>At present , related research Recombinant Human Granulocyte Colony-stimulating Factor apply AHSCT China . The purpose study evaluate efficacy safety PEG-rhG-CSF lymphoma patient autologous hematopoietic stem cell transplantation . Eligible patient randomly assign PEG-rhG-CSF group rhG-CSF group . Patients PEG-rhG-CSF group receive PEG-rhG-CSF day +1 transplantation dose 100μg/kg . Patients weight 45kg suggest dose 6 mg . Patients control group receive rhG-CSF day +1 transplantation dose 5μg/kg per day recovery neutrophil .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>1 . Patients age 18 65 year . 2 . Lymphoma patient requirement autologous hematopoietic stem cell transplantation . 3 . The collected CD34+ cells≥1×10E6/kg . 4 . ECOG score ≤2 . 5 . Heart lung normal . 6 . Blood creatinine ≤1.5×ULN . 7 . ALT , AST , TBIL ≤2 ×ULN 8 . Not pregnancy . 9 . Written inform consent acquire . 1 . Had receive autologous hematopoietic stem cell transplantation allogeneic transplantation . 2 . Severe uncontrolled infectious disease : HIV , HCV , syphilis , ALT , chronic hepatitis B . 3 . Serious complication , severe infection , heart , lung , liver kidney dysfunction . 4 . LVEF &lt; 55 % . 5 . Allergic product biological product genetically engineer Escherichia coli strain . 6 . Refused take contraceptive measure study period subsequent 1 year . 7 . Severe mental neurological disorder . 8 . Serious heart , lung , central nervous system disorder . 9 . Sickle cell anemia , hemolytic anemia hematologic disease . 10 . Participate drug clinical trial 30 day screen . 11 . Other situation investigator consider contraindication study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>